Xovoltib 50 Mg

Afatinib Tablets

Description: Afatinib Tablets are a medication used in the treatment of certain types of non-small cell lung cancer (NSCLC) and other cancers. The active ingredient, Afatinib, is a tyrosine kinase inhibitor that targets and blocks the activity of specific proteins involved in cancer cell growth and division.

Salt Composition:

• Afatinib (30 mg, 40 mg, or 50 mg): A tyrosine kinase inhibitor that selectively blocks the activity of the epidermal growth factor receptor (EGFR) and other related receptors.

Key Features:

• Targeted Therapy: Specifically targets and inhibits the activity of EGFR and other related receptors involved in tumor growth.
• Effective Dosage: Available in various strengths (30 mg, 40 mg, 50 mg) for personalized treatment based on the patient’s condition.
• Oral Administration: Tablets are taken orally, offering a convenient option for ongoing cancer treatment.

Benefits:

• Cancer Management: Effective in treating advanced or metastatic non-small cell lung cancer and other cancers with specific genetic mutations.
• Reduced Tumor Growth: Helps slow down or halt the growth of cancer cells by inhibiting key growth factors.
• Improved Outcomes: Can lead to better overall treatment outcomes and potentially extend survival in patients with specific cancer types.

American Brand Names:

• Gilotrif

Indian Brand Names:

• Afatinib Tablets (Various local brands)

Related Keywords: Afatinib Tablets, cancer treatment, tyrosine kinase inhibitor, EGFR inhibitor, NSCLC treatment, targeted therapy, oral cancer medication, advanced lung cancer, Afatinib dosage, Indian cancer tablets.